Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-1 gp120 V3 loop for structure-based drug design.

Suzanne Sirois1, Tobias Sing, Kuo-Chen Chou

  • 1Université du Québec à Montréal, Chemistry Department, Montréal, Québec, Canada H3C 3P8. suzanne.sirois@gmail.com

Current Protein & Peptide Science
|October 27, 2005
PubMed
Summary

Understanding HIV-1 cell entry requires studying the envelope protein gp120 and its interactions with CD4 and coreceptors. This review focuses on the V3 loop

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNAPred_Prot: Identification of DNA-Binding Proteins Using Composition- and Position-Based Features.

Applied bionics and biomechanics·2022
Same author

Special Issue on Digital Pathology, Tissue Image Analysis, Artificial Intelligence, and Machine Learning: Approximation of the Effect of Novel Technologies on Toxicologic Pathology.

Toxicologic pathology·2021
Same author

HistoNet: A Deep Learning-Based Model of Normal Histology.

Toxicologic pathology·2021
Same author

iHyd-LysSite (EPSV): Identifying Hydroxylysine Sites in Protein Using Statistical Formulation by Extracting Enhanced Position and Sequence Variant Feature Technique.

Current genomics·2020
Same author

Two Latest Hot Researches in Medicinal Chemistry.

Current topics in medicinal chemistry·2020
Same author

RETRACTED ARTICLE: An insightful 20-year recollection since the birth of pseudo amino acid components.

Amino acids·2020

Area of Science:

  • Virology
  • Immunology
  • Structural Biology

Background:

  • HIV-1 entry depends on envelope protein gp120 binding to CD4 and coreceptors (CCR5/CXCR4).
  • Coreceptor antagonists and neutralizing antibodies targeting gp120 are potential therapeutic and vaccine strategies.
  • HIV-1 gp120's complex protective mechanisms enable rapid escape from drug and antibody pressures.

Purpose of the Study:

  • To review advances in understanding HIV-1 coreceptor usage and inhibition.
  • To highlight the critical role of the gp120 V3 loop in HIV-1 entry, evolution, and therapeutic targeting.
  • To emphasize the need for improved structural insights for rational drug and vaccine design.

Main Methods:

  • Review of existing literature on HIV-1 entry mechanisms.

Related Experiment Videos

  • Analysis of genotype-phenotype relationships in coreceptor usage.
  • Focus on structural biology of gp120-coreceptor interactions.

    • Main Results:

    • The V3 loop of gp120 is central to HIV-1 coreceptor tropism and immune evasion.
    • Understanding V3 loop's role is crucial for developing effective antiretrovirals and vaccines.
    • Structural insights into V3 loop interactions are key to overcoming viral escape mechanisms.

    Conclusions:

    • Targeting coreceptors and gp120 remains a challenge due to viral adaptability.
    • Further research into the V3 loop's structural biology is essential for next-generation HIV therapies and vaccines.
    • Integrating genotype, phenotype, and structural data will drive progress in combating HIV-1.